Autoassembling peptides for the treatment of pulmonary bulla

Patent metadata

Field	Value
Publication number	US-10245299-B2
Application number	US-201515124636-A
Country	US
Kind code	B2
Filing date	Mar 10, 2015
Priority date	Mar 10, 2014
Publication date	Apr 2, 2019
Grant date	Apr 2, 2019

Abstract

Materials and methods for treatment of pulmonary bulla are provided. A peptide comprising between about 7 amino acids and about 32 amino acids in a solution may be introduced to a target site. A hydrogel barrier may be provided at the target site in order to treat the pulmonary bulla.

First claim

The invention claimed is:

1. A method of treating a pulmonary bulla in a subject, comprising:
introducing a delivery device to a target area of the pulmonary bulla of the subject;
positioning an end of the delivery device in the target area in which a treatment of the pulmonary bulla is desired;
administering, through the delivery device, a solution comprising an amphiphilic self-assembling peptide comprising between about 7 amino acids and 32 amino acids in an effective amount and in an effective concentration to the target area to form a hydrogel barrier under physiological conditions of the target area to treat the pulmonary bulla;
removing the delivery device from the target area; and
collapsing the pulmonary bulla prior or subsequent to administering the solution.

2. The method of claim 1 , wherein a cavity of the pulmonary bulla is filled with the solution through connecting bronchioles.

3. The method of claim 2 , further comprising inserting an endotracheal tube through a primary bronchus of a lung of the subject.

4. A method of treating a pulmonary bulla in a subject, comprising:
introducing a delivery device to a target area of the pulmonary bulla of the subject;
positioning an end of the delivery device in the target area in which a treatment of the pulmonary bulla is desired;
administering, through the delivery device, a solution comprising an amphiphilic self-assembling peptide comprising between about 7 amino acids and 32 amino acids in an effective amount and in an effective concentration to the target area to form a hydrogel barrier under physiological conditions of the target area to treat the pulmonary bulla, wherein the administering the solution comprises administering the solution in a single dose;
administering the solution until a volume of the target area is filled; and
removing the delivery device from the target area.

5. A method of treating a pulmonary bulla in a subject, comprising:
introducing a delivery device to a target area of the pulmonary bulla of the subject;
positioning an end of the delivery device in the target area in which a treatment of the pulmonary bulla is desired;
administering, through the delivery device, a solution comprising an amphiphilic self-assembling peptide comprising between about 7 amino acids and 32 amino acids in an effective amount and in an effective concentration to the target area to form a hydrogel barrier under physiological conditions of the target area to treat the pulmonary bulla; and
removing the delivery device from the target area,
wherein the subject has been diagnosed with at least one of emphysema and chronic obstructive pulmonary disease (COPD) prior to administering the solution comprising the amphiphilic self-assembling peptide.

6. A method of treating a pulmonary bulla in a subject, comprising:
introducing a delivery device to a target area of the pulmonary bulla of the subject;
positioning an end of the delivery device in the target area in which a treatment of the pulmonary bulla is desired;
administering, through the delivery device, a solution comprising an amphiphilic self-assembling peptide comprising between about 7 amino acids and 32 amino acids in an effective amount and in an effective concentration to the target area to form a hydrogel barrier under physiological conditions of the target area to treat the pulmonary bulla; and
removing the delivery device from the target area,
wherein the solution comprising the amphiphilic self-assembling peptide comprises (RADA) 4 (SEQ ID NO: 1) at a concentration of about 0.5 weight per volume (w/v) percent.

7. The method of claim 6 , wherein the solution comprising the amphiphilic self-assembling peptide comprises a concentration of calcium chloride of about 0.125 M.

8. A method of treating a pulmonary bulla in a subject, comprising:
introducing a delivery device to a target area of the pulmonary bulla of the subject;
positioning an end of the delivery device in the target area in which a treatment of the pulmonary bulla is desired;
administering, through the delivery device, a solution comprising an amphiphilic self-assembling peptide comprising between about 7 amino acids and 32 amino acids in an effective amount and in an effective concentration to the target area to form a hydrogel barrier under physiological conditions of the target area to treat the pulmonary bulla;
removing the delivery device from the target area; and
preparing the solution comprising the amphiphilic self-assembling peptide by adding the amphiphilic self-assembling peptide to a buffer comprising at least two salts and adding the buffer to the solution,
wherein the amphiphilic self-assembling peptide is selected from the group consisting of (RADA) 4 (SEQ ID NO: 1), (IEIK) 3 I (SEQ ID NO: 2), and (KLDL) 3 (SEQ ID NO: 3).

Assignees

• 3 D Matrix Ltd

Inventors

• Mehta Manav
• Tsukada Hisashi
• Gil Eun Seok
• Gilbert Karl
• Kobayashi Satoru

Classifications

• A61M16/0463

  combined with suction tubes, catheters or the like; Outside connections · CPC title

• A61B17/34

  Trocars; Puncturing needles · CPC title

• A61K38/16 Primary

  Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof {(enzyme inhibitors A61K38/005)} · CPC title

• A61K38/08

  Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title

• A61K38/10

  Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title